When was Raynovent founded?

Raynovent was founded in 2018 and raised its 1st funding round 5 years after it was founded.

Where is Raynovent located?

Raynovent is headquartered in Guangzhou, China.

Is Raynovent a funded company?

Raynovent is a funded company, having raised a total of $***** in its 1st and only funding round, a Series C round on Jan 01, 2023.

When was the latest funding round of Raynovent?

Raynovent's latest funding was a $***** Series C round on Jan 01, 2023, with participation from 6 investors. Its primary sector is Biopharma Outsourcing. In China, the Biopharma Outsourcing sector has seen $50.6M in funding in 2026 to date.

Where does Raynovent rank among its competitors?

Raynovent ranks 37th amongst 573 active competitors, of which 11 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Access Infinity, which secured an undisclosed amount in Feb, 2026.

Who are the top competitors of Raynovent?

Raynovent's top competitors include Lynx Analytics, OPEN Health and Secura Bio. Among them, Access Infinity secured the most recent funding round in February, 2026.

Raynovent - 2026 Company Profile, Team, Funding & Competitors

Raynovent is a series C company based in Guangzhou (China), founded in 2018 by Xiaoxin Chen, Chaofeng Long and Haijun Li. It operates as a Provider of marketing services. Raynovent has raised $53.6M in funding from Efung Capital and Yide Fund. The company has 573 active competitors, including 11 funded and 50 that have exited. Its top competitors include companies like Lynx Analytics, OPEN Health and Secura Bio.

Company Details

Website: www.raynovent.com/
Email ID: *****@raynovent.com
Phone Number: +86 **********

Key Metrics

Founded Year

2018

Location

Guangzhou, China

Stage

Series C

Total Funding

$53.6M in 1 round

Latest Funding Round

Series C, Jan 01, 2023, $*****

Investors

Efung Capital & 7 more

Ranked

37^th among 573 active competitors

Similar Companies

Lynx Analytics & 633 more

View Raynovent's full profile

Raynovent has raised a total funding of $53.6M over 1 round. Its latest funding round was a Series C round on Jan 01, 2023 for $*****. 6 investors participated in its latest round. Raynovent has 8 institutional investors.

Here is the list of recent funding rounds of Raynovent:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 01, 2023	1580587	Series C	4520628	4826539	3730144	1533018

Access funding benchmarks and valuations. Sign up today!

View details of Raynovent's funding rounds and investors

The founders of Raynovent are Xiaoxin Chen, Chaofeng Long and Haijun Li.

Here are the details of Raynovent's key team members:

Xiaoxin Chen: Co-Founder of Raynovent.
Chaofeng Long: Co-Founder of Raynovent.
Haijun Li: Co-Founder of Raynovent.

View details of Raynovent's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Raynovent include Lynx Analytics, OPEN Health and Secura Bio. Here is the list of Top 10 competitors of Raynovent, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Lynx Analytics 2010, Singapore (Singapore), Seed	Developer of artificial intelligence software for pharmaceutical commercial decision support	$10M	-	60/100
2nd	OPEN Health 2016, Marlow (United Kingdom), Acquired	Provider of healthcare marketing services	$5.28M	LBO France, Amulet Capital Partners	59/100
3rd	Secura Bio 2018, Henderson (United States), Series A	Provider of consulting services for market access and health outcomes	$55M	Athyrium Capital Management	49/100
4th	GBA Group 1975, Hamburg (Germany), Acquired	Provider of drinking water testing, environmental analysis, and marketing services to the pharmaceutical industry	-	Adiuva Capital	44/100
5th	Abacus Medicine 2004, Copenhagen (Denmark), Series A	Consulting services for market access, health economics and outcomes research	$57.6M	Chr. Augustinus Factories	43/100
6th	Target RWE 2017, Durham (United States), Acquired	Provider of marketing services to the pharmaceutical industry	-	Norwest, VentureSouth	43/100
7th	BioPharm Communications 2005, New Hope (United States), Acquired	Provider of marketing services to pharmaceutical and biopharma companies	-	Boathouse Capital, Abacus Finance Group & 2 others	43/100
8th	Access Infinity London (United Kingdom), Seed	Provider of pharmaceutical market access consulting services and digital tools	-	CBPE	42/100
9th	Bridge Medical 2011, Chatham (United Kingdom), Acquired	Provider of evidence and outcomes research for biopharmaceutical companies	-	-	41/100
10th	bpcruk 2016, United Kingdom, Public	Provider of marketing services to biopharma sector	-	Scientia Ventures	40/100
37th	Raynovent 2018, Guangzhou (China), Series C	Provider of marketing services	$53.6M	Lake Bleu Capital, Efung Capital & 6 others	30/100